Clinical trial
PTK787/ZK 222584 in Treating Patients With Unresectable Malignant Mesothelioma
NCT00053885
Study timeline
Study start (unknown)2003-07-01Date precision: month
Registry last updated2016-07-01
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Malignant Mesotheliomaunresolved
Interventions
PTK787/ZK 222584DRUG
Sponsors & collaborators
Alliance for Clinical Trials in Oncologylead sponsor
National Cancer Institute (NCI)collaborator
Mapped research locations
ChicagoIllinois, United States4New YorkNew York, United States3Washington D.C.District of Columbia, United States3DallasTexas, United States2St LouisMissouri, United States2San FranciscoCalifornia, United States2San DiegoCalifornia, United States2DurhamNorth Carolina, United States2MinneapolisMinnesota, United States2Las VegasNevada, United States2MemphisTennessee, United States2BuffaloNew York, United States2
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT00053885 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.